Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000933
Chunk: 8

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 8
---
, share split, reverse share
split, Depositary Share-Ordinary Share ratio change or other similar transaction) and (ii) the VWAP for the period on the applicable Additional
VWAP Purchase Date, beginning at the latest of (A) the applicable VWAP Purchase Termination Time with respect to the corresponding VWAP
Purchase referred to in clause (i) of the proviso in the second sentence of hereof on such Additional VWAP Purchase
Date, (B) the applicable Additional VWAP Purchase Termination Time with respect to the most recently completed prior Additional VWAP Purchase
on such Additional VWAP Purchase Date, as applicable, and (C) the time at which the Depositary has acknowledged the receipt of, and confirmed
the processing of, a Depositary Instruction Letter with respect to all Purchase Shares subject to all prior VWAP Purchases and Additional
VWAP Purchases (as applicable), including, without limitation, those that have been effected on the same Business Day as the applicable
Additional VWAP Purchase Date with respect to which the applicable Additional VWAP Purchase relates (such latest of (ii)(A), (ii)(B) and
(ii)(C) above, the “”), and ending at the earliest of (X) 2:00 p.m., Eastern
time, on such Additional VWAP Purchase Date, (Y) such time, from and after the Additional VWAP Purchase Commencement Time for such Additional
VWAP Purchase, that the total number (or volume) of Depositary Shares traded on the Principal Market has exceeded the applicable Additional
VWAP Purchase Share Volume Maximum, and (Z) such time, from and after the Additional VWAP Purchase Commencement Time for such Additional
VWAP Purchase, that the Sale Price has fallen below the applicable Additional VWAP Purchase Minimum Price Threshold (such earliest of
(X), (Y) and (Z) above, the “”). Notwithstanding the foregoing, in the event
that (a) the Investor is the holder of any Depositary Shares on the Additional VWAP Purchase Date that were the subject of an Additional
VWAP Purchase Notice for such Additional VWAP Purchase Date, and (b) if within three (3) Business Days following an Additional VWAP Purchase
Date, the Company issues or sells any Depositary Shares or Ordinary Share Equivalents (calculated on an as converted, as exercised basis),
in each case other than pursuant to an Exempt Issuance, pursuant to which